Blog

Jul 21, 2024, 10:33

Filippo Montemurro: RWE of drug-drug interactions on abemaciclib

Filippo Montemurro, Senior Medical Director at F. Hoffmann La Roche, shared a post on X:

“Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study | NPJ Breast Cancer
Very nice paper on the impact of concomitant drugs in pts treated with abemaciclib using the DRUG-PIN tool.

Authors: Simone Scagnoli, Simona Pisegna, Angela Toss, Roberta Caputo, Michelino De Laurentiis, Michela Palleschi, Ugo de Giorgi, Enrico Cortesi, Agnese Fabbri, Alessandra Fabi, Ida Paris, Armando Orlandi, Giuseppe Curigliano, Carmen Criscitiello, Ornella Garrone, Gianluca Tomasello, Giuliana D’Auria, Patrizia Vici, Enrico Ricevuto, Federica Domati, Claudia Piombino, Sara Parola, Roberta Scafetta, Alessio Cirillo, Beatrice Taurelli Salimbeni, Francesca Sofia Di Lisa, Lidia Strigari, Robert Preissner, Maurizio Simmaco, Daniele Santini, Paolo Marchetti, Andrea Botticelli. ”

Source: Filippo Montemurro/X

Agnese Fabbri Alessandra Fabi Alessio Cirillo Andrea Botticelli Angela Toss Armando Orlandi Beatrice Taurelli Salimbeni cancer carmen criscitiello Claudia Piombino Daniele Santini Enrico Cortesi Enrico Ricevuto Federica Domati Filippo Montemurro Francesca Sofia Di Lisa Gianluca Tomasello Giuliana D'Auria Giuseppe Curigliano Ida Paris Lidia Strigari Maurizio Simmaco Michela Palleschi Michelino De Laurentiis OncoDaily Oncology Ornella Garrone Paolo Marchetti Patrizia Vici Robert Preissner Roberta Caputo Roberta Scafetta Sara Parola Simona Pisegna Simone Scagnoli Ugo de Giorgi

FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

Karen Knudsen: Clinical trials are the most advanced form of cancer care

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results